druggable < drugs < dss

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by drugs

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]

Ident.	Authors (with country if any)	Title
000015 (2020)	Patricia Schlagenhauf [Suisse] ; Martin P. Grobusch [Pays-Bas] ; Julian D. Maier [Suisse] ; Philippe Gautret [France]	Repurposing antimalarials and other drugs for COVID-19.
000019 (2020)	Annie Ladoux [France] ; Stéphane Azoulay [France] ; Christian Dani [France]	[SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
000052 (2020)	Joëlle Micallef [France] ; Thomas Soeiro [France] ; Annie-Pierre Jonville-Béra [France]	Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection.
000056 (2020)	Joachim Alexandre [France] ; Jean-Luc Cracowski [France] ; Vincent Richard [France] ; Béatrice Bouhanick [France]	Drugs acting on renin angiotensin system and use in ill patients with COVID-19.
000286 (2020)	Frederic Sacher [France] ; Laurent Fauchier [France] ; Serge Boveda [France] ; Christian De Chillou [France] ; Pascal Defaye [France] ; Jean Claude Deharo [France] ; Estelle Gandjbakhch [France] ; Vincent Probst [France] ; Ariel Cohen [France] ; Christophe Leclercq [France]	Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection.
000444 (2020)	Benjamin Pradère [France] ; Guillaume Ploussard [France] ; James W F. Catto [Royaume-Uni] ; Morgan Rouprêt [France] ; Vincent Misrai [France]	The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is "Safe Better than Sorry"?
000653 (2020)	S. Sebastian [Royaume-Uni] ; H A Gonzalez [Royaume-Uni] ; Laurent Peyrin-Biroulet [France]	Safety of drugs during previous and current coronavirus pandemics: Lessons for IBD.
000776 (2020)	Alan G. Fraser [Royaume-Uni, Belgique] ; Piotr Szyma Ski [Pologne] ; Elizabeth Macintyre [France] ; Martin Landray [Royaume-Uni]	Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic?
000838 (2020)	Jean-Marie Vaugeois [France]	Psychotropics drugs with cationic amphiphilic properties may afford some protection against SARS-CoV-2: A mechanistic hypothesis.
000880 (2020)	Bruno O. Villoutreix [France] ; Philippe H. Beaune [France] ; Ryad Tamouza [France] ; Rajagopal Krishnamoorthy [France] ; Marion Leboyer [France]	Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders.
000921 (2020)	Nicolas Venisse [France]	Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.
000922 (2020)	Florian Lemaitre [France] ; Caroline Solas [France] ; Matthieu Grégoire [France] ; Laurence Lagarce [France] ; Laure Elens [Belgique] ; Elisabeth Polard [France] ; Béatrice Saint-Salvi [France] ; Agnès Sommet [France] ; Michel Tod [France] ; Chantal Barin-Le Guellec [France]	Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.
000951 (2020)	Markus Zeitlinger [Autriche] ; Birgit C P. Koch [Pays-Bas] ; Roger Bruggemann [Pays-Bas] ; Pieter De Cock [Belgique] ; Timothy Felton [Royaume-Uni] ; Maya Hites [Belgique] ; Jennifer Le [États-Unis] ; Sonia Luque [Espagne] ; Alasdair P. Macgowan [Royaume-Uni] ; Deborah J E. Marriott [Australie] ; Anouk E. Muller [Pays-Bas] ; Kristina Nadrah [Slovénie] ; David L. Paterson [Australie] ; Joseph F. Standing [Royaume-Uni] ; João P. Telles [Brésil] ; Michael Wölfl-Duchek [Autriche] ; Michael Thy [France] ; Jason A. Roberts [Australie, France]	Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents.
000A11 (2020)	Patrick Brest [France] ; Jonathan Benzaquen [France] ; Daniel J. Klionsky [États-Unis] ; Paul Hofman [France] ; Baharia Mograbi [France]	Open questions for harnessing autophagy-modulating drugs in the SARS-CoV-2 war: hope or hype?
000A15 (2020)	Allan Sauvat [France] ; Fabiola Ciccosanti [Italie] ; Francesca Colavita [Italie] ; Martina Di Rienzo [Italie] ; Concetta Castilletti [Italie] ; Maria Rosaria Capobianchi [Italie] ; Oliver Kepp [France] ; Laurence Zitvogel [France, République populaire de Chine] ; Gian Maria Fimia [Italie] ; Mauro Piacentini [Italie] ; Guido Kroemer [France, République populaire de Chine, Suède]	On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2.
000D01 (2020)	Andrés Pizzorno [France] ; Blandine Padey [France] ; Julia Dubois [France] ; Thomas Julien [France] ; Aurélien Traversier [France] ; Victoria Dulière [France] ; Pauline Brun [France] ; Bruno Lina [France] ; Manuel Rosa-Calatrava [France] ; Olivier Terrier [France]	In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
001106 (2020)	Coralie Valle [France] ; Baptiste Martin [France] ; Franck Touret [France] ; Ashleigh Shannon [France] ; Bruno Canard [France] ; Jean-Claude Guillemot [France] ; Bruno Coutard [France] ; Etienne Decroly [France]	Drugs against SARS-CoV-2: What do we know about their mode of action?
001201 (2020)	Cédric Annweiler ; Zhijian Cao [République populaire de Chine] ; Yingliang Wu [République populaire de Chine] ; Emmanuelle Faucon ; Stéphanie Mouhat ; Hervé Kovacic ; Jean-Marc Sabatier	Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients.
001599 (2020)	Giuseppe Di Lorenzo [Italie] ; Rossella Di Trolio [Italie] ; Zisis Kozlakidis [France] ; Giuseppina Busto [Italie] ; Concetta Ingenito [Italie] ; Luciana Buonerba [Italie] ; Claudia Ferrara [Italie] ; Annamaria Libroia [Italie] ; Gianluca Ragone [Italie] ; Concetta Dello Ioio [Italie] ; Beatrice Savastano [Italie] ; Mario Polverino [Italie] ; Ferdinando De Falco [Italie] ; Simona Iaccarino [Italie] ; Emilio Leo [Italie]	COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature.
001690 (2020)	Mathieu Gendrot [France] ; Julien Andreani [France] ; Manon Boxberger [France] ; Priscilla Jardot [France] ; Isabelle Fonta [France] ; Marion Le Bideau [France] ; Isabelle Duflot [France] ; Joel Mosnier [France] ; Clara Rolland [France] ; Hervé Bogreau [France] ; Sébastien Hutter [France] ; Bernard La Scola [France] ; Bruno Pradines [France]	Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation.
001695 (2020)	Paul Gougis [France] ; Charlotte Fenioux [France] ; Christian Funck-Brentano [France] ; Marianne Veyri [France] ; Joseph Gligorov [France] ; Caroline Solas [France] ; Jean-Philippe Spano [France]	Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "drugs" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "drugs" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    drugs
}}

---

This area was generated with Dilib version V0.6.37. Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021